Dresden, Germany

René Martin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor René Martin

Introduction

René Martin is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of radiofluorination, with a focus on producing radiofluorinated compounds. His work has implications in various scientific and medical applications.

Latest Patents

René Martin holds 2 patents related to his innovative methods. His latest patents include a method for producing a radiofluorinated compound that features an aromatic or heteroaromatic ring carrying fluorine as the first substituent. This method involves a bonding unit that can bind to a peptide or peptide mimetic, along with a spacer group connected to the bonding unit and the ring. The process includes providing a precursor with specific substituents and reacting it with a fluoride anion in the presence of an activation salt to create the desired radiofluorinated compound.

Career Highlights

Throughout his career, René Martin has worked with prominent companies in the biochemical and pharmaceutical sectors. He has been associated with Abx Advanced Biochemical Compounds GmbH and Bayer Pharma Aktiengesellschaft, where he has contributed to various innovative projects.

Collaborations

René Martin has collaborated with several professionals in his field, including René Smits and Ronny Hesse. These collaborations have further enhanced his research and development efforts.

Conclusion

René Martin's contributions to the field of radiofluorination and his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to influence advancements in biochemical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…